GDOC
Goldman Sachs Future Health Care Equity ETF
Price Chart
Latest Quote
$33.97
+0.27 (+0.81%)
Current Price
| Previous Close | $33.69 |
| Open | $34.12 |
| Day High | $34.19 |
| Day Low | $33.66 |
| Volume | 5,491 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.34% |
| Net Assets | $20.12M |
| Expense Ratio | 0.75% |
| Category | Health |
| Fund Family | Goldman Sachs |
| Net Asset Value | $33.75 |
| Premium/Discount | 0.64% |
| Quarterly Dividend Yield | 0.34% |
| P/E Ratio | 32.31 |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $33.36 |
| SMA50 | $32.78 |
| SMA200 | $33.91 |
| RSI | 66.90 |
| ATR | 0.3578 |
| Rel Volume | 1.15 |
Performance History
| Week | +1.49% |
| Month | +3.58% |
| Quarter | +5.85% |
| 6 Months | -3.84% |
| YTD | -4.34% |
| Year | +9.26% |
| 3 Years | +1.68% |
| 10 Years | -12.17% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $33.97 | 5,491 |
| 2026-06-22 | $33.69 | 66,400 |
| 2026-06-18 | $33.13 | 14,300 |
| 2026-06-17 | $33.26 | 500 |
| 2026-06-16 | $33.40 | 300 |
| 2026-06-15 | $33.47 | 300 |
| 2026-06-12 | $33.60 | 200 |
| 2026-06-11 | $33.79 | 100 |
| 2026-06-10 | $33.38 | 1,700 |
| 2026-06-09 | $33.78 | 300 |
| 2026-06-08 | $33.27 | 2,200 |
| 2026-06-05 | $33.40 | 100 |
| 2026-06-04 | $33.54 | 900 |
| 2026-06-03 | $32.74 | 100 |
| 2026-06-02 | $32.61 | 400 |
| 2026-06-01 | $33.08 | 100 |
| 2026-05-29 | $33.47 | 100 |
| 2026-05-28 | $33.63 | 800 |
| 2026-05-27 | $32.95 | 700 |
| 2026-05-26 | $33.12 | 100 |
About Goldman Sachs Future Health Care Equity ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.